Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

KKR divests 5.8 percent stake in JB Chemicals & Pharma for Rs 1460 crore

Dr Reddy's Swiss to sell entire stake in Dr Reddy's Venezuela C.A.

Ruchika Sharma15 April 2024 5:38 PM IST

Hyderabad: Through a recent BSE filing, Dr Reddy's Labs has informed that the wholly owned subsidiary of the Company, namely, Dr...

Sanofi Wayrilz wins USFDA approval for adults with immune thrombocytopenia

Innate Pharma announces advancement of Sanofi-developed NK Cell Engager SAR443579/ IPH6101 progressing to Phase 2 for blood cancer patients

Ruchika Sharma15 April 2024 3:17 PM IST

France: Innate Pharma SA has announced that the first patient was dosed in the Phase 2 dose expansion part of the Sanofi-sponsored clinical trial...

Granules recalls over 33000 bottles BP medication in US

Glenmark Pharma recalls 6528 bottles of BP drug in US

Ruchika Sharma15 April 2024 1:36 PM IST

New Delhi: Glenmark Pharmaceuticals is recalling 6,528 bottles of a medication prescribed for the treatment of high blood pressure in the...

Nigeria rolls out new 5-in-1 vaccine against meningitis

Ruchika Sharma15 April 2024 12:36 PM IST

This new multivalent conjugate vaccine was 13 years in the making and was based on a partnership between PATH and the Serum Institute of India.

Bayer AG arm AskBio names Mansuo Shannon as Chief Scientific Officer

Ruchika Sharma14 April 2024 1:00 PM IST

Research Triangle Park: Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has...

Arvinas, Novartis collaborate for development, commercialization of ARV-766 for prostate cancer

Ruchika Sharma14 April 2024 10:00 AM IST

New Haven: Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, has...

Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag International

Kenya drug regulator recalls a batch of JnJ children cough syrup

Ruchika Sharma13 April 2024 4:15 PM IST

Nairobi: Kenya's drug regulator said on thursday it is recalling a batch of Johnson & Johnson children's cough syrup, following...

Granules India enters high growing peptide segment, CDMO business by acquiring Senn Chemicals

Granules India gets Zero 483's from USFDA for Unit V facility in AP

Ruchika Sharma13 April 2024 12:08 PM IST

Telangana: Granules India has informed in a BSE filing that the Company's Unit V facility located at Anakapally, Visakhapatnam, Andhra ...

USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plant

USFDA concludes inspection of Lupin Dabhasa facility with no observations

Ruchika Sharma13 April 2024 11:48 AM IST

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a GMP...

Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs deal

Novartis tender offer for MorphoSys AG commences

Ruchika Sharma12 April 2024 3:30 PM IST

Basel: Novartis has published the offer document for the voluntary public takeover offer by its wholly owned subsidiary Novartis BidCo AG for all...

SII partners with Univercells to bring affordable personalized oncology to masses

Ruchika Sharma12 April 2024 2:38 PM IST

Pune: In a landmark collaboration announced, Serum Institute of India (SII), the world's largest vaccine manufacturer, has joined forces with...

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

Roche gets CE Mark for companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for Enhertu

Ruchika Sharma12 April 2024 12:54 PM IST

Tucson: Roche has announced the approval of the CE Mark for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx to identify...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok